Jason Alvarez is an Ophthalmology physician. OpenAlex indexes 16 publications with 328 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1201 First Colonial Rd
Virginia Beach, VA 234542217
Telephone
757-425-5550Provider last certified this registry record 10 May 2021.
Industry payments
31 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year202513 payments
- ABBVIE INC.Program year202515 payments
- Glaukos CorporationProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
77.8%Prostaglandin Analog53.6%Bimatoprost58%Latanoprost39%Travoprost2%Lumigan2%Part D + Part B<11 patientsCarbonic Anhydrase Inhibitor10.9%Dorzolamide-Timolol73%Brinzolamide10%Simbrinza10%Dorzolamide Hcl6%Part D<11 patients+ 7 more classes in this area
Respiratory
5.2%Histamine-1 Receptor Antagonist3.4%Azelastine Hcl100%Part D≥39 patientsMast Cell Stabilizer1.8%Cromolyn Sodium100%Part D≥22 patientsMusculoskeletal
5.1%Cyclooxygenase Inhibitor3.4%Ketorolac Tromethamine100%Part D≥65 patientsNonsteroidal Anti-inflammatory Drug1.7%Diclofenac Sodium100%Part D≥25 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Oral minocycline for the treatment of retinitis pigmentosa–associated cystoid macular edema: results of a phase I/II clinical trial
Graefe s Archive for Clinical and Experimental Ophthalmology
2023 - Eye Disease Prevalence and VF-14 Validation Among Patients Experiencing Homelessness and Presenting for Ophthalmic Examination in Baltimore, Maryland
Translational Vision Science & Technology
2023 - Baltimore Homeless Eye Disease Study2021
- The Role of Preoperative Bevacizumab in Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy without Tractional Retinal Detachment2019
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”